Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-02

Clinical Trial Update: Fatty Acid Supplementation in Children With ASD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating fatty acid supplementation in children with autism spectrum disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sarah Keim | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-04-02